World Health Organization (WHO) is recommending widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among children in sub-Saharan Africa and in other regions with moderate to high P. falciparum malaria transmission. The recommendation is based on results from an ongoing pilot programme in Ghana, Kenya & Malawi that has reached more than 800 000 children since 2019.
The vaccine is developed by British drugmaker GlaxoSmithKline (GSK). Many vaccines exist against viruses and bacteria but this was the first time that the WHO recommended broad use of a vaccine against a human parasite. The vaccine acts against Plasmodium falciparum, one of five parasite species and the most deadly. The symptoms of malaria are fever, headaches, and muscle pain, then cycles of chills, fever, and sweating.
Important takeaways for all competitive exams:
National News India Approves Anhydrous Ammonia Fertilizer to Boost Sustainable Farming India has approved the…
The Reserve Bank of India (RBI) got permission from the Indian Government to roll out…
The e-Zero FIR system has been introduced by the Gujarat Government to facilitate cyber financial…
Gujarat has secured its position as a frontrunner among India’s states with Geographical Indication (GI)…
On 29th July, 2026 International Tiger Day will be observed worldwide, to raise the global…
In July 2026, Sarnath got included in the UNESCO World Heritage List which helped Uttar…